Big Gain For Hillstream BioPharma Inc.
Hillstream BioPharma Inc. (HILS:NASDAQ) rocketted at $0.61, a gain of 43.4%. On Fri, Dec 09, 2022, HILS:NASDAQ touched a New 2-Week High of $0.61. The stock appeared on our News Catalysts scanner on Thu, Dec 01, 2022 at 10:45 AM in the 'AGREEMENT' category. From Fri, Nov 25, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Dec 09, 2022 at $1.06 with a volume of 10M+.
About Hillstream BioPharma Inc. (HILS:NASDAQ)
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug...
Top 10 Gainers:
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 1007.59%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 117.57%
- ClearOne, Inc. (CLRO:NASDAQ), 73.4%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 53.24%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 43.41%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 40.39%
- Cardiol Therapeutics Inc. (CRDL:NASDAQ), 38.3%
- PainReform Ltd. (PRFX:NASDAQ), 37.21%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 35.97%
- Acer Therapeutics Inc. (ACER:NASDAQ), 35.67%